NASDAQ · RLAY

Relay Therapeutics, Inc.

Smart money pulse

What insiders and funds are doing

Selling Insiders: as of Nov 12 Funds: as of Jun 30, 2026
−1000+100 −36
  • account_balance
    163 funds bought, 93 sold in the quarter ended Jun 30, 2026. 54 were new holders.
  • info
    3 real insider sales in 12 months. $83.3K in total, not counting planned sales.

Pulse runs from −100 (everyone selling) to +100 (everyone buying). Half comes from insiders: real buyers vs. real sellers in the last 90 days (Form 4). Half comes from funds: funds that bought vs. funds that sold last quarter (13F). 13F is a snapshot of long positions on the last day of the quarter, filed up to 45 days later. It does not show short positions or trades since then. This is data, not advice.

Who owns it

260 funds report owning RLAY , up from 243

Holdings as of Jun 30, 2026
New54
Added109
Held41
Trimmed56
Sold out37

Last quarter

Who bought and who sold

Change in shares held, biggest funds first. Bars stop at ±100%.

Insider trades · last 12 months

Real buys and sales

● Open-market buy● Open-market sale
CEOCFOOther officersDirectorsDecJanFebMarAprMayJunJulAugSepOctNovOpen-market sale · Oct 28 · $56KOpen-market sale · Oct 28 · $27.4K

Showing 2 real trades. Bigger dot means a bigger trade.

Showing every filing. Dashed circles are routine: grants, tax withholding, option exercises and planned sales.

Top holders

Biggest funds in RLAY

As of Jun 30, 2026
FundOwnsValueChange
Sb Investment Advisers (uk) Ltd—$522M+0%
Fmr LLC—$376M+444%
Casdin Capital, LLC—$300M+11%
BlackRock, Inc.—$286M+18%
Perceptive Advisors LLC—$264M+45%

"Owns" is shares reported divided by shares outstanding.

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K).

This is data, not investment advice. About StockToast